Novo Nordisk

novonordisk.com

Novo Nordisk is a leading global healthcare company focused on diabetes care and other serious chronic diseases. The company develops and produces innovative medicines, including insulin and GLP-1 receptor agonists, to improve the lives of patients. With a strong commitment to research and development, Novo Nordisk differentiates itself through its pioneering scientific breakthroughs and sustainable business practices. The company has a significant market presence, with sales reaching DKK 204.7 billion in the first nine months of 2024, reflecting a 23% increase in Danish kroner. Novo Nordisk's extensive portfolio and dedication to patient care position it as a key player in the global healthcare market.